Joincare Pharmaceutical Group Co., Ltd. logo

Joincare Pharmaceutical Group Co., Ltd. (600380)

Market Closed
11 Aug, 06:57
SSE SSE
¥
10. 45
+0.17
+1.6537%
¥
21.07B Market Cap
- P/E Ratio
0.72% Div Yield
3.19M Volume
- Eps
¥ 10.28
Previous Close
Add Transaction
Day Range
10.23 10.47
Year Range
9.08 14.21
Want to track 600380 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600380 closed today higher at ¥10.45, an increase of 1.6537% from yesterday's close, completing a monthly increase of 10.9342% or ¥1.03. Over the past 12 months, 600380 stock lost -9.3669%.
600380 pays dividends to its shareholders, with the most recent payment made on Jun 26, 2026. The next estimated payment will be in In 10 months on Jun 26, 2027 for a total of ¥0.22.
The last earnings report, released on Apr 01, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Joincare Pharmaceutical Group Co., Ltd. has completed 7 stock splits, with the recent split occurring on Oct 08, 2018.
The company's stock is traded on one exchange.

600380 Chart

People also search for

SAIC Motor Corporation Limited
¥ 10.46
-0.1908%
Seres Group Co., Ltd.
¥ 55.52
-0.9102%
Great Wall Motor Co., Ltd.
¥ 15.69
0%
Fuyao Glass Industry Group Co., Ltd.
¥ 56.63
+0.0707%
China Tourism Group Duty Free Corporation Limited
¥ 56.01
-0.409%

Joincare Pharmaceutical Group Co., Ltd. (600380) FAQ

What is the stock price today?

The current price is ¥10.45.

On which exchange is it traded?

Joincare Pharmaceutical Group Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600380.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.72%.

What is its market cap?

As of today, the market cap is 21.07B.

Has Joincare Pharmaceutical Group Co., Ltd. ever had a stock split?

Joincare Pharmaceutical Group Co., Ltd. had 7 splits and the recent split was on Oct 08, 2018.

Joincare Pharmaceutical Group Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Xiong Yu CEO
SSE Exchange
CNE000001816 ISIN
CN Country
14,365 Employees
26 Jun 2026 Last Dividend
8 Oct 2018 Last Split
9 May 2001 IPO Date

Overview

Joincare Pharmaceutical Group Industry Co.,Ltd., established in 1992 and headquartered in Shenzhen, China, is a leading player in the pharmaceutical and healthcare product market primarily within China. The company focuses on the research, development, production, and sale of a wide range of pharmaceuticals and health care products. With a strong dedication to improving human health, Joincare Pharmaceutical has diversified its product offerings across chemical and traditional Chinese medicine preparations, biologics, health products, diagnostic reagents and equipment, and medical devices.

Products and Services

  • Chemical Preparation for Drugs: This includes medicines for various therapeutic areas such as digestive tract, cardiovascular and cerebrovascular disorders, antimicrobial, anti-tumor, assisted reproductive, and neurological treatments. Also, it encompasses over-the-counter (OCT) drugs for various health needs.
  • Traditional Chinese Drug Preparation: Production focuses on anti-tumor and cold remedies, leveraging the centuries-old knowledge and practices of traditional Chinese medicine.
  • Chemical APIs and Intermediates: The company manufactures active pharmaceutical ingredients (APIs) and intermediates, essential components for the production of various drugs, showcasing their integrated capabilities in drug manufacturing.
  • Diagnostic Reagents and Equipment: Joincare produces a range of diagnostic products, including reagents and equipment, supporting healthcare providers in disease identification and management.
  • Health Products: Under various brands such as Taita, Jingxin, and Eagle’s, the company offers health supplements and products, catering to the growing demand for wellness and preventive healthcare.
  • Biologics: The biologics range includes advanced therapies like monoclonal antibodies, vaccines, recombinant therapeutic proteins, among other biological treatments, marking the company's presence in the high-growth biopharmaceutical sector.
  • Self-produced Dietary Supplement and Medical Devices: In addition to pharmaceuticals, Joincare also brings to market its own branded dietary supplements and medical devices, broadening its health care offerings.

Contact Information

Address: Joincare Pharmaceutical Group Building, Shenzhen, China, 518057
Phone: 86 75 5862 52368